Date Title Description PDF
23 Jul 2026 On P&L The Company releases the press release related to the first half of 2026 financial results Download
23 Jul 2026 On P&L The Company releases the first half 2026 financial results presentation Download
06 May 2026 On P&L The Company releases the press release related to the first three months of 2026 financial results. Download
06 May 2026 On P&L The Company releases the first three months of 2026 financial results presentation. Download
25 Feb 2026 On P&L The Company releases the press release related to the full year 2025 financial results. Download

Pages

Date Title Description PDF
26 Jan 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 19 January and 25 January 2024 Download
19 Jan 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 12 January and 18 January 2024 Download
12 Jan 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 January and 11 January 2024 Download
05 Jan 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 29 December 2023 and 4 January 2024 Download
29 Dec 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 22 December and 28 December 2023 Download

Pages

Date Title Description PDF
08 Jan 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the fourth quarter of 2017 Download
21 Dec 2017 Préstamos, créditos y avales ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies Download
08 Nov 2017 Información sobre Resultados ROVI releases the press release related to the nine-month period ended 30 September 2017 results Download
08 Nov 2017 Información sobre Resultados ROVI releases the presentation related to the nine-month period ended 30 September 2017 results. Download
24 Oct 2017 Otros sobre negocio y situación financiera The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project. Download

Pages